Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chaitra S. Ujjani, MD
Fred Hutch/University of Washington Cancer Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Oregon Health & Sciences University
Portland, Oregon, United States
- M D Anderson Cancer Center
Houston, Texas, United States
- Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
- Fred Hutch/university of Washington Cancer Consortium
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Mar 2021
- Primary completion
- 1 Jan 2023
- Completion
- 1 Jul 2024
- Last update posted
- 2 Aug 2024
- Registered enrollment
- 350
- Registry id
- NCT04852822
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.